US BANCORP \DE\ - ABCELLERA BIOLOGICS INC ownership

ABCELLERA BIOLOGICS INC's ticker is ABCL and the CUSIP is 00288U106. A total of 118 filers reported holding ABCELLERA BIOLOGICS INC in Q3 2021. The put-call ratio across all filers is 0.49 and the average weighting 1.2%.

Quarter-by-quarter ownership
US BANCORP \DE\ ownership history of ABCELLERA BIOLOGICS INC
ValueSharesWeighting
Q3 2023$10,276
-28.2%
2,234
+0.8%
0.00%
Q2 2023$14,315
+64.2%
2,216
+91.7%
0.00%
Q1 2023$8,716
-39.8%
1,156
-19.2%
0.00%
Q4 2022$14,486
+1348.6%
1,430
+1942.9%
0.00%
Q3 2022$1,000
-90.9%
70
-86.0%
0.00%
Q2 2021$11,000
+266.7%
500
+495.2%
0.00%
Q1 2021$3,000840.00%
Other shareholders
ABCELLERA BIOLOGICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Founders Fund VII Management, LLC 3,773,530$37,320,00092.58%
Gruss & Co., LLC 308,570$3,052,00026.27%
Founders Fund Growth Management, LLC 407,017$4,025,00011.55%
Belmont Capital, LLC 510,000$5,044,0005.95%
HARVARD MANAGEMENT CO INC 4,105,095$40,599,0005.05%
GUARDIAN CAPITAL ADVISORS LP 3,736,414$40,129,0005.01%
Intellectus Partners, LLC 1,091,505$10,795,0003.84%
ArchPoint Investors 617,213$6,104,0002.49%
BRANDYWINE MANAGERS, LLC 56,976$563,0001.85%
Casdin Capital, LLC 1,650,000$16,319,0001.07%
View complete list of ABCELLERA BIOLOGICS INC shareholders